ARTICLE | Finance

Weaving in China

China VC part of $12M round for GeneWeave to get molecular diagnostic to market

March 5, 2012 8:00 AM UTC

Last week's $12 million series A round for molecular diagnostics play GeneWeave Biosciences Inc. is designed to get a first product to market.

New investor Decheng Capital, a Chinese VC, led the round and existing investors Claremont Creek Ventures and X/Seed Capital also participated...